Vimarsana
Biggest News Aggregation in the World

Page 25 - Viewray Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viewray Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viewray Inc Today - Breaking & Trending Today

ViewRay Announces Third Quarter 2022 Results - Vimarsana News

ViewRay Announces Third Quarter 2022 Results

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2022. Third Quarter...

ViewRay: Q3 Earnings Snapshot - Vimarsana News

ViewRay: Q3 Earnings Snapshot

OAKWOOD VILLAGE, Ohio (AP) _ ViewRay Inc. (VRAY) on Tuesday reported a loss of $26.1 million in its third quarter. On a per-share basis, the Oakwood Village, Ohio-based company said it had a loss of 14 cents.

Source: apnews.com
ViewRay Announces Third Quarter 2022 Results - Vimarsana News

ViewRay Announces Third Quarter 2022 Results

/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2022. Third Quarter...

ViewRay (VRAY) to Release Quarterly Earnings on Tuesday - Vimarsana News

ViewRay (VRAY) to Release Quarterly Earnings on Tuesday

ViewRay (NASDAQ:VRAY – Get Rating) is scheduled to announce its earnings results after the market closes on Tuesday, November 1st. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. ViewRay has set its FY 2022 guidance at EPS.Investors interested in participating in the company’s conference call can do so using […]

MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer - Vimarsana News

MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the final primary endpoint results from the phase III randomized single-center MIRAGE trial...